(Q34202452)

31 July 2017

1 reference

title

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. (English)

1 reference

31 July 2017

1 reference

1 reference

1 reference

J B Segal

1

1 reference

31 July 2017

R L McNamara

2

1 reference

31 July 2017

M R Miller

3

1 reference

31 July 2017

N R Powe

4

1 reference

31 July 2017

S N Goodman

5

1 reference

31 July 2017

K A Robinson

6

1 reference

31 July 2017

E B Bass

7

1 reference

31 July 2017

publication date

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

31 July 2017

published in

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

CD001938

1 reference

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001938

Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001938

Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001938

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001938

Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001938

Incidence of and risk factors for atrial fibrillation in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001938

Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001938

Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001938

Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001938

Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001938

10.1002/14651858.CD001938

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference